TGFB1 and cardiac hypertrophy: Furthermore, our findings highlight the critical role of the β-adrenergic system in TGF-β1-induced cardiac phenotype and indicate that β-blockers may act beneficially in cardiac hypertrophy and dysfunction at least in part by normalizing regulatory mechanisms of cellular hypertrophy and energy metabolism.